The role of collagen in cancer: from bench to bedside

S Xu, H Xu, W Wang, S Li, H Li, T Li, W Zhang… - Journal of translational …, 2019 - Springer
Collagen is the major component of the tumor microenvironment and participates in cancer
fibrosis. Collagen biosynthesis can be regulated by cancer cells through mutated genes …

The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies

VM Perez, JF Kearney, JJ Yeh - Frontiers in oncology, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is notorious for a dense fibrotic stroma that is
interlaced with a collagen-based extracellular matrix (ECM) that plays an important role in …

Tumor organoid models in precision medicine and investigating cancer-stromal interactions

R Xu, X Zhou, S Wang, C Trinkle - Pharmacology & therapeutics, 2021 - Elsevier
Tumor development and progression require chemical and mechanical cues derived from
cellular and non-cellular components in the tumor microenvironment, including the …

Vasculogenic mimicry: become an endothelial cell “but not so much”

M Fernández-Cortés, D Delgado-Bellido… - Frontiers in …, 2019 - frontiersin.org
Blood vessels supply all body tissues with nutrients and oxygen, take away waste products
and allow the arrival of immune cells and other cells (pericytes, smooth muscle cells) that …

Pancreatic cancer stem cells: A state or an entity?

PC Hermann, B Sainz Jr - Seminars in Cancer Biology, 2018 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer,
has a median overall survival of 6–12 months and a 5-year survival of less than 7%. While …

Targeting tumor-stromal interactions in pancreatic cancer: impact of collagens and mechanical traits

P Maneshi, J Mason, M Dongre… - Frontiers in Cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst outcomes among cancers
with a 5-years survival rate of below 10%. This is a result of late diagnosis and the lack of …

[HTML][HTML] Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry

X Zhang, J Zhang, H Zhou, G Fan, Q Li - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Vasculogenic mimicry (VM) is a vascular formation mechanism used by aggressive tumor
cells. VM provides an alternative pathway for adequate blood perfusion and challenges the …

Tissue engineering modalities in skeletal muscles: focus on angiogenesis and immunomodulation properties

AR Namjoo, FN Abrbekoh, S Saghati, H Amini… - Stem Cell Research & …, 2023 - Springer
Muscular diseases and injuries are challenging issues in human medicine, resulting in
physical disability. The advent of tissue engineering approaches has paved the way for the …

Resistance to gemcitabine in pancreatic ductal adenocarcinoma: A physiopathologic and pharmacologic review

T Koltai, SJ Reshkin, TMA Carvalho, D Di Molfetta… - Cancers, 2022 - mdpi.com
Simple Summary PDAC is one of the most malignant tumors and its treatment, whether
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …

Vascular mimicry: changing the therapeutic paradigms in cancer

N Fathi Maroufi, S Taefehshokr, MR Rashidi… - Molecular biology …, 2020 - Springer
Cancer is a major problem in the health system, and despite many efforts to effectively treat
it, none has yet been fully successful. Angiogenesis and metastasis are considered as major …